SHERIDAN, WYOMING – May 6, 2025 – BD (Becton, Dickinson and Company), a global leader in medical technology, has announced its participation in the upcoming Bank of America Securities Health Care Conference, scheduled for Tuesday, May 13, 2025, at 1:00 pm Eastern Time. The live webcast of the presentation will be available on the BD investor relations website, with a replay accessible afterward for those unable to attend the live event.
BD’s Commitment to Innovation in Health Care
BD continues to lead the charge in transforming the medical technology landscape. With a vast portfolio of cutting-edge solutions, BD plays a critical role in advancing medical discovery, diagnostics, and the delivery of care. Through its presentation at the prestigious Bank of America Securities Health Care Conference, BD aims to further demonstrate how its innovations enhance the safety, efficiency, and quality of care for both patients and healthcare providers.
The company is at the forefront of developing technologies that address some of the most pressing challenges in healthcare. From enhancing clinical therapy to providing laboratory solutions that accurately detect diseases, BD is helping to shape the future of healthcare delivery.
Event Details and Access
The live webcast of BD's presentation can be accessed via the company’s investor relations website at investors.bd.com. After the event, a replay will also be made available on the same page, allowing stakeholders and investors to revisit the presentation at their convenience.
About BD
BD stands as one of the largest global medical technology companies, known for its innovative solutions that support the healthcare community worldwide. The company’s portfolio includes advanced technologies, services, and solutions that benefit clinicians, laboratory scientists, and researchers across the globe. With a workforce of over 70,000 employees, BD is committed to improving patient care while enhancing the efficiency and safety of healthcare delivery processes.
BD’s partnerships with healthcare providers, researchers, and global health organizations further solidify its role as a key player in advancing both medical treatments and healthcare infrastructures. By collaborating closely with customers, BD is helping to address complex global health challenges, lower costs, improve healthcare outcomes, and expand access to critical services.
Strategic Impact of BD's Innovations
As a leader in medical technology, BD’s innovations contribute to reducing healthcare inefficiencies, improving patient outcomes, and lowering overall healthcare costs. Through strategic partnerships and its global presence, BD is advancing clinical processes while ensuring healthcare professionals have access to the most reliable and effective tools. The company’s focus on safety, accuracy, and efficiency directly impacts the quality of care provided to patients, making BD’s technologies indispensable in modern healthcare settings.
BD’s participation in the Bank of America Securities Health Care Conference further reinforces the company’s commitment to sharing its vision for the future of health care and the ways in which its solutions can continue to make a difference.